A Real-World Study About Anemia in Chronic Kidney Disease in China（DASHENG）

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

20000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-01

Study Completion Date

2027-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Anemia affects the quality of life of CKD patients and increases the risk of CKD progression. we conducted a real-world study on patients with anemia in CKD to analyze the disease characteristics and treatment in Chinese patients with CKD-anemia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Early Screening and Diagnosis of CKD

NCT02841371

Kidney; Disease (Functional) Chronic Kidney Disease

RECRUITING

A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases

NCT05188885

Chronic Kidney Disease

RECRUITING

Renal Protocol Protection in CKD Patients

NCT04024514

HCC CKD

UNKNOWN NA

Screening and Assessing the Risk Factors and Complications of Chronic Kidney Disease

NCT03246191

Chronic Kidney Disease

UNKNOWN

Serum Hepcidin, Haemoglobin Level and Iron Status in Chronic Kidney Disease Patients (CKD) With Anaemia

NCT04102319

CKD Stage 4

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Anemia adversely affects the quality of life of CKD patients and increases the risk of CKD progression.

This study utilize data from approximately 20 medical centers across China. It aims to:

1. Analyze the disease characteristics, current diagnostic and treatments in Chinese patients with CKD-anemia.
2. Evaluate the safety and efficacy profiles of different drugs used for CKD-anemia.
3. Explore the direct medical costs associated with CKD-anemia management within real-world clinical practice in China.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anemia in Chronic Kidney Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. diagnosis of CKD (e.g., "%chronic kidney disease%", "%chronic nephropathy%", "%renal failure%", "%nephritis%" for complete ICD-9/10 code mapping\*)
2. record of hemodialysis (HD) or peritoneal dialysis (PD) (refer to Attachment 2 for dialysis identification algorithms)
3. ≥2 eGFR measurements \<60 mL/min/1.73m² (calculated using CKD-EPI equation) with ≥3-month interval (excluding acute kidney injury)

Exclusion Criteria

1. Non-renal anemia due to trauma, traffic accidents, major hemorrhage, or other confirmed etiologies (e.g., acute hemorrhagic anemia, nutritional deficiency anemia, hemolytic anemia);
2. Diagnosis of acute kidney disease (AKD) without chronic kidney disease (CKD) comorbidity;
3. Incomplete critical data elements (including age, sex, or visit dates).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No